Back to Search

Updated Inserter for Open Angle Glaucoma Treatment

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Recruiting Observational Study
Open Angle Glaucoma (OAG) Ocular Hypertension (OH)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Glaukos Corporation · Industry
Who this trial is looking for

This trial is looking for adults with open-angle glaucoma to evaluate a new tool used for a specific eye implant. Participants will help test how well this new inserter works during the treatment process.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with open-angle glaucoma.
  • I am 18 years of age or older.

You may not be able to join if

  • I am breast-feeding.
  • I am pregnant.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Trial Locations

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of Open-angle glaucoma * 18 years of age or older Exclusion Criteria: * Subject who is breast-feeding or pregnant
Contacts

Study Director

949-739-8749

ClinicalResearch@glaukos.com

CONTACT

NCT ID: NCT07400926 Source: ClinicalTrials.gov